Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Research into Cold Cancers Heating Up

Activation and expansion are essential for success in both autologous and allogeneic therapies.

Development of Gamma-Delta T-Cell Therapies

Continuous manufacturing and a quality-by-design development approach are a natural fit.

QbD for Small-Molecule Continuous Process Development

Topic

Feliza Mirasol is the science editor for 

Articles

The Phase IIa study will test HTL0039732 in combination with immunotherapy to boost responses in resistant solid tumors and broaden treatment choices.

Cancer Research UK Partners with Nxera on Next-Stage Trial for HTL0039732 

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

Corstasis Therapeutics plans to launch the product in the United States in the fourth quarter of 2025.

FDA Approves Cortasis Nasal Spray, Enbumyst, for Edema

Cheryl Barton is director of PharmaVision, 

Novo Nordisk’s Wegovy will be competing with Madrigal Pharmaceuticals’ Rezdiffra in the metabolic dysfunction-associated steatohepatitis arena. 

Competition in MASH Is Heating Up as GLP-1s Gate-Crash the Party

The 2024 edition of the annual conference, held in Milan, attracted more than 59,000 professionals from across the bio/pharmaceutical landscape.

CPHI Frankfurt Expected to Draw More Than 60,000 Attendees in October

The two organizations are collaborating on an integrated translational biology platform for the development of radiopharmaceuticals.

Medicines Discovery Catapult and Crown Bioscience Create Alliance for Radiopharmaceuticals

Mike Hennessy Jr. is the Chairman and CEO of 

Scientific discovery, technological evolution, and market demands are constantly reshaping the landscape.

Building Resilience and Precision in Pharma Development

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Videos

Aaron Cowley, Recipharm Advanced Bio; Renee Hart, LumaCyte; and Vibha Jawa, EpiVax, go behind the headlines to delve deeper into recent market deals driven by Big Pharma patent cliffs and the complex manufacturing of ATMPs. 

Behind the Headlines Episode 24: Surging Implementation of Sequence Event Reporting in CMC Analytics, Billion Dollar Deals Push Further Consolidation or Collapse, and an Analytics Wish List

Bothe data integrity and quality of data are critical for drug discovery, manufacturing efficiency, regulatory compliance, and patient safety.

PDA 2025: How Data-Driven AI Transforms Quality Control & Development

The partnership, which has received £118 million (US$158 million) in research funding, aims to establish a better understanding not only of how the body fights infection, but also how vaccines protect it.

Oxford, EIT Address Urgent Problem with AI Vaccine Research

Evonne Brennan, evonne@evonnebrennan.com, is an experienced educator and consultant delivering tailored tuition and courses in pharmaceutical formulation and processing. Evonne is a member of 

This article previews some formulation topics discussed in the Pharma Fundamentals series, which aims to enhance learning for professionals in pharmaceutical drug development and manufacturing.

Drug Development

Research into Cold Cancers Heating Up

Development of Gamma-Delta T-Cell Therapies

QbD for Small-Molecule Continuous Process Development